Hosted on MSN
Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis
THURSDAY, Aug. 28, 2025 (HealthDay News) -- Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart failure among patients receiving maintenance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback